BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 19428264)

  • 21. BNCT for skin melanoma in extremities: updated Argentine clinical results.
    Menéndez PR; Roth BM; Pereira MD; Casal MR; González SJ; Feld DB; Santa Cruz GA; Kessler J; Longhino J; Blaumann H; Jiménez Rebagliati R; Calzetta Larrieu OA; Fernández C; Nievas SI; Liberman SJ
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S50-3. PubMed ID: 19375342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tolerance of normal human brain to boron neutron capture therapy.
    Coderre JA; Hopewell JW; Turcotte JC; Riley KJ; Binns PJ; Kiger WS; Harling OK
    Appl Radiat Isot; 2004 Nov; 61(5):1083-7. PubMed ID: 15308196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of an intramuscular xenograft model of canine osteosarcoma in mice for evaluation of the effects of radiation therapy.
    Coomer AR; Farese JP; Milner R; Taylor D; Salute ME; Rajon DA; Bova FJ; Siemann DW
    Am J Vet Res; 2009 Jan; 70(1):127-33. PubMed ID: 19119958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homogeneous boron targeting of heterogeneous tumors for boron neutron capture therapy (BNCT): chemical analyses in the hamster cheek pouch oral cancer model.
    Heber EM; Trivillin VA; Nigg DW; Itoiz ME; Gonzalez BN; Rebagliati RJ; Batistoni D; Kreimann EL; Schwint AE
    Arch Oral Biol; 2006 Oct; 51(10):922-9. PubMed ID: 16696934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Combined use of irradiation and DNA tumor vaccine to treat canine oral malignant melanoma: a pilot study].
    Herzog A; Buchholz J; Ruess-Melzer K; Lang J; Kaser-Hotz B
    Schweiz Arch Tierheilkd; 2013 Feb; 155(2):135-42. PubMed ID: 23385072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Boron delivery system for neutron capture therapy of cancer].
    Nakamura H
    Rinsho Ketsueki; 2008 May; 49(5):294-301. PubMed ID: 18572805
    [No Abstract]   [Full Text] [Related]  

  • 27. Prompt gamma neutron activation analysis of 10B and Gd in biological samples at the MEPhI reactor.
    Khokhlov VF; Zaitsev KN; Beliayev VN; Kulakov VN; Lipengolts AA; Portnov AA
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S251-3. PubMed ID: 19375332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of human interferons and 60cobalt radiation on canine and feline tumour cells-preclinical studies].
    Kessler M; Hammer AS; Bailey MQ; Tempel KH; Matis U
    Zentralbl Veterinarmed A; 1996 Dec; 43(10):599-609. PubMed ID: 9065060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insights into the use of gadolinium and gadolinium/boron-based agents in imaging-guided neutron capture therapy applications.
    Deagostino A; Protti N; Alberti D; Boggio P; Bortolussi S; Altieri S; Crich SG
    Future Med Chem; 2016 May; 8(8):899-917. PubMed ID: 27195428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spontaneous tumors in dogs and cats: models for the study of cancer biology and treatment.
    MacEwen EG
    Cancer Metastasis Rev; 1990 Sep; 9(2):125-36. PubMed ID: 2253312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility study on the utilization of boron neutron capture therapy (BNCT) in a rat model of diffuse lung metastases.
    Bakeine GJ; Di Salvo M; Bortolussi S; Stella S; Bruschi P; Bertolotti A; Nano R; Clerici A; Ferrari C; Zonta C; Marchetti A; Altieri S
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S332-5. PubMed ID: 19394841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose distribution and clinical response of glioblastoma treated with boron neutron capture therapy.
    Matsuda M; Yamamoto T; Kumada H; Nakai K; Shirakawa M; Tsurubuchi T; Matsumura A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S19-21. PubMed ID: 19375933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Boron neutron capture therapy at the crossroads: challenges and opportunities.
    Barth RF
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S3-6. PubMed ID: 19467879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor necrosis following radiation therapy and/or chemotherapy for canine osteosarcoma.
    Withrow SJ; Powers BE; Straw RC; Thrall DE; Gillette EL; LaRue SM; Richter SL
    Chir Organi Mov; 1990; 75(1 Suppl):29-31. PubMed ID: 2249550
    [No Abstract]   [Full Text] [Related]  

  • 35. Palliative radiation therapy for canine osteosarcoma.
    Mayer MN; Grier CK
    Can Vet J; 2006 Jul; 47(7):707-9. PubMed ID: 16898117
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of Boron Neutron Capture Therapy (BNCT) on normal liver regeneration: towards a novel therapy for liver metastases.
    Cardoso JE; Trivillin VA; Heber EM; Nigg DW; Calzetta O; Blaumann H; Longhino J; Itoiz ME; Bumaschny E; Pozzi E; Schwint AE
    Int J Radiat Biol; 2007 Oct; 83(10):699-706. PubMed ID: 17729164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
    Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperthermia effects in animals with spontaneous tumors.
    Gillette EL
    Natl Cancer Inst Monogr; 1982 Jun; 61():361-4. PubMed ID: 6757753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Local hyperthermia and canine tumours.
    Dobson JM; Frew DG
    Vet Rec; 1989 Aug; 125(7):162. PubMed ID: 2800279
    [No Abstract]   [Full Text] [Related]  

  • 40. A novel boronated-porphyrin as a radio-sensitizing agent for boron neutron capture therapy of tumours: in vitro and in vivo studies.
    Jori G; Soncin M; Friso E; Vicente MG; Hao E; Miotto G; Colautti P; Moro D; Esposito J; Rosi G; Nava E; Sotti G; Fabris C
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S321-4. PubMed ID: 19376726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.